BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26503156)

  • 1. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
    Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
    BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of retinoid receptors in sebaceous cell carcinoma.
    Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
    J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
    Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling.
    Collins CA; Watt FM
    Dev Biol; 2008 Dec; 324(1):55-67. PubMed ID: 18805411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
    Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
    Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
    Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
    Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does β-catenin have a role in pathogenesis of sebaceous cell carcinoma of the eyelid?
    Jayaraj P; Sen S; Kashyap S; Sharma A; Pushker N; Bajaj MS; Ghose S; Chosdol K
    Br J Ophthalmol; 2011 Feb; 95(2):284-7. PubMed ID: 20813740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid.
    Rigas PK; Kase S; Rao NA
    Eur J Ophthalmol; 2009; 19(5):702-7. PubMed ID: 19787585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
    Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
    Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Shh and Wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: clinicopathologic study.
    Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):370-7. PubMed ID: 23249701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid.
    Tanahashi J; Kashima K; Daa T; Yada N; Fujiwara S; Yokoyama S
    J Cutan Pathol; 2009 Sep; 36(9):983-6. PubMed ID: 19017040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
    Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
    Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
    Jakobiec FA; Mendoza PR
    Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sebaceoma of the eyelid.
    Yonekawa Y; Jakobiec FA; Zakka FR; Fay A
    Ophthalmology; 2012 Dec; 119(12):2645.e1-4. PubMed ID: 23207023
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
    Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
    Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
    Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
    Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study.
    Cheng AY; Lan J; Lee CH
    J Dermatol; 2022 Jun; 49(6):600-606. PubMed ID: 35318716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.